NCT03595527View on ClinicalTrials.gov

Universal HIV Screening and Targeted HCV Screening in Emergency Department

NACompletedINTERVENTIONAL
Enrollment

6,350

Participants

Timeline

Start Date

July 10, 2018

Primary Completion Date

October 10, 2019

Study Completion Date

October 10, 2020

Conditions
Hepatitis CHiv
Interventions
DIAGNOSTIC_TEST

HIV and HCV screening

HIV test: ARCHITECT HIV Ag/Ab Combo, Abbott HCV test: ARCHITECT Anti-HCV, Abbott

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal, Montreal

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Ministere de la Sante et des Services Sociaux

OTHER

collaborator

Gilead Sciences

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER